TAK

Takeda Pharmaceutical Company Limited
D

TAK

14.355
USD
-0.11
(-0.76%)
مفتوح الان
حجم التداول
35,909
الربح لكل سهم
134
العائد الربحي
4.59
P/E
63
حجم السوق
45,352,010,566
أصول ذات صلة
AZN
AZN
-0.610
(-0.84%)
72.020 USD
BMY
BMY
-0.660
(-1.36%)
47.795 USD
GILD
GILD
-2.400
(-2.07%)
113.810 USD
GSK
GSK
-0.270
(-0.71%)
37.695 USD
JNJ
JNJ
-1.235
(-0.73%)
167.120 USD
LLY
LLY
1.70
(0.21%)
814.65 USD
MRK
MRK
-0.130
(-0.15%)
84.570 USD
NVO
NVO
-1.550
(-2.16%)
70.150 USD
NVS
NVS
-1.090
(-0.93%)
116.590 USD
PFE
PFE
-0.290
(-1.17%)
24.520 USD
SNY
SNY
-0.640
(-1.27%)
49.705 USD
المزيد
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.